title: Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
authors.affiliation: Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Faculty Hospital Motol, V úvalu 84, 150 06 Prague 5, Czech Republic. jan.plzak@lf1.cuni.cz
authors.forename: Jan
authors.initials: J
authors.lastname: Plzák
authors.forename: Jan
authors.initials: J
authors.lastname: Betka
authors.forename: Karel
authors.initials: K
authors.lastname: Smetana
authors.forename: Martin
authors.initials: M
authors.lastname: Chovanec
authors.forename: Herbert
authors.initials: H
authors.lastname: Kaltner
authors.forename: Sabine
authors.initials: S
authors.lastname: André
authors.forename: Roman
authors.initials: R
authors.lastname: Kodet
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Gabius
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D037502:Galectin 3 / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D037502:Galectin 3